Loading…
Reported covered position: Policy Counsel Senate Republican Whip
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Public Law 115-271 The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment Act. Public Law 116-136 CARES (Coronavirus Aid, Relief, and Economic Security) Act. H.R. 6102 VALID (Verifying Accurate Leading-edge IVCT Development) Act of 2020. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs). Proposals to advance policies related to effective pain management. Proposals related to the advancement of testing and detection of TBI (Traumatic Brain Injuries). Issues related to medical device cybersecurity.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2020 · first_quarter · Q1
Public Law 115-271 The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment Act. Public Law 116-136 CARES (Coronavirus Aid, Relief, and Economic Security) Act. H.R. 6102 VALID (Verifying Accurate Leading-edge IVCT Development) Act of 2020. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs). Proposals to advance policies related to effective pain management. Proposals related to the advancement of testing and detection of TBI (Traumatic Brain Injuries). Issues related to medical device cybersecurity.
Source: Senate LDA
Public Law 111-148 Section 6002 The Physician Payments Sunshine Act. H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Public Law 111-148 Section 6002 The Physician Payments Sunshine Act. H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R. 1892 Bipartisan Budget Act of 2018. Title IV Section 50414 - Strengthening Rules in Case of Competition for Diabetes Testing Strips. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals to introduce policies to prevent the spread of Anti-Microbial Resistant Bacteria.
H.R. 1892 Bipartisan Budget Act of 2018. Title IV Section 50414 - Strengthening Rules in Case of Competition for Diabetes Testing Strips. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals to introduce policies to prevent the spread of Anti-Microbial Resistant Bacteria.
H.R. 2997 21st Century AIRR Act. (FAA Reauthorization).
H.R. 2997 21st Century AIRR Act. (FAA Reauthorization).
H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Fighting Opioid Abuse in Transportation Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2848 Fighting Opioid Abuse in Transportation Act.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R.5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals related to the prevention of Anti-Microbial Resistant Bacteria. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R.5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals related to the prevention of Anti-Microbial Resistant Bacteria. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R.5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals related to the prevention of Anti-Microbial Resistant Bacteria. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R.2997 - 21st Century AIRR Act (FAA Reauthorization Act).
H.R.2997 - 21st Century AIRR Act (FAA Reauthorization Act).
H.R.2997 - 21st Century AIRR Act (FAA Reauthorization Act).
Protecting Access to Diabetes Supplies Act of 2017
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017. Proposals to improve the DME competitive bidding program for diabetes products. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs). Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals to introduce policies to prevent the spread of Anti-Microbial Resistant Bacteria.
Protecting Access to Diabetes Supplies Act of 2017
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017. Proposals to improve the DME competitive bidding program for diabetes products. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals to support appropriate Medicare coverage for heart failure technology. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
H.R. 6 21st Century CURES Act, Sec. 2228. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity. Issues related to the implementation of the FDA Device Accountability Act of 2016.
National Clinical Care Commission Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
National Clinical Care Commission Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding payments across healthcare sites of service.
National Clinical Care Commission Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
Safe and Accurate Food Labeling Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 764 National Bioengineered Food Disclosure Standard. H.R. 1599 Safe and Accurate Food Labeling Act of 2015 Proposals to reduce adult malnutrition and hospital re-admissions.
Middle Class Health Benefits Tax Repeal Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
Middle Class Health Benefits Tax Repeal Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Initiatives to support patient access to therapeutic nutrition. Proposals to reduce adult malnutrition and hospital re-admissions.
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Initiatives regarding Trade Implications of International Food Labeling Requirements. Proposals to reduce adult malnutrition and hospital re-admissions.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding payments across healthcare sites of service.
Puerto Rico Oversight, Management, and Economic Stability Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
Puerto Rico Oversight, Management, and Economic Stability Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
Puerto Rico Oversight, Management, and Economic Stability Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
Puerto Rico Oversight, Management, and Economic Stability Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding payments across healthcare sites of service.
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding payments across healthcare sites of service.
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
Middle Class Health Benefits Tax Repeal Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
Middle Class Health Benefits Tax Repeal Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
National Diabetes Clinical Care Commission Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
National Diabetes Clinical Care Commission Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
National Diabetes Clinical Care Commission Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding payments across healthcare sites of service.
A bill to reauthorize and amend the National Sea Grant College Program Act, and for other purposes.
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 764 National Bioengineered Food Disclosure Standard. H.R. 1599 Safe and Accurate Food Labeling Act of 2015 Proposals to reduce adult malnutrition and hospital re-admissions.
Permanent CFC Look-Through Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1946: Tax Relief Extension Act of 2015 H.R. 880, the American Research and Competitiveness Act of 2015, H.R. 1430, Permanent CFC Look-Through Act of 2015 Proposals to reform domestic and international tax structures.
Consolidated Appropriations Act, 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2029 Consolidated Appropriations Act of 2016, Sec. 101. Protecting Americans from Tax Hikes Act of 2015, Sec. 121, Sec. 144, Sec. 174. Proposals to reform domestic and international tax structures.
Consolidated Appropriations Act, 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2029 Consolidated Appropriations Act 2016, Sec. 503. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015 Proposals to reform the Medicare new technology add-on payment provision for inpatient services. Proposed Hospital Inpatient Prospective Payment System Rule.
Consolidated Appropriations Act, 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2029 Consolidated Appropriations Act of 2016, Sec. 101. Protecting Americans from Tax Hikes Act of 2015, Sec. 121, Sec. 144, Sec. 174. Proposals to reform domestic and international tax structures.
Consolidated Appropriations Act, 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2029 Consolidated Appropriations Act 2016, Sec. 503. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015 Proposals to reform the Medicare new technology add-on payment provision for inpatient services. Proposed Hospital Inpatient Prospective Payment System Rule.
H.R.22 Fixing America's Surface Transportation Act - issues related to truck weight.
H.R.22 Fixing America's Surface Transportation Act - issues related to truck weight.
Country of Origin Labeling Amendments Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
Country of Origin Labeling Amendments Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2029 Consolidated Appropriations Act 2016, Sec. 503. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015 Proposals to reform the Medicare new technology add-on payment provision for inpatient services. Proposed Hospital Inpatient Prospective Payment System Rule.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2029 Consolidated Appropriations Act 2016, Sec. 503. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015 Proposals to reform the Medicare new technology add-on payment provision for inpatient services. Proposed Hospital Inpatient Prospective Payment System Rule.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
American Research and Competitiveness Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1946: Tax Relief Extension Act of 2015 H.R. 880, the American Research and Competitiveness Act of 2015, H.R. 1430, Permanent CFC Look-Through Act of 2015 Proposals to reform domestic and international tax structures.
S. 1946: Tax Relief Extension Act of 2015 H.R. 880, the American Research and Competitiveness Act of 2015, H.R. 1430, Permanent CFC Look-Through Act of 2015 Proposals to reform domestic and international tax structures.
To improve cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes.
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 754 Cybersecurity Information Sharing Act.
To improve cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes.
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 754 Cybersecurity Information Sharing Act.
H.R. 1295, Medical Device Tax Elimination Act. Proposals to reform domestic and international tax structures.
H.R. 1295, Medical Device Tax Elimination Act. Proposals to reform domestic and international tax structures.
Safe and Accurate Food Labeling Act of 2014
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 4432 Safe and Accurate Food Labeling Act. Proposals to reduce adult malnutrition and hospital re-admissions.
Safe and Accurate Food Labeling Act of 2014
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Initiatives to reduce patient malnutrition and hospital readmissions. H.R. 4432 Safe and Accurate Food Labeling Act. Initiatives to support patient access to therapeutic nutrition.
Safe and Accurate Food Labeling Act of 2014
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 4432 Safe and Accurate Food Labeling Act. Initiatives to reduce patient malnutrition and hospital readmissions
American Research and Competitiveness Act of 2014
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2260 EXPIRE Act. H.R. 4438 American Research and Competitiveness Act of 2013. Proposals to reform domestic and international tax structures.
S. 2260 EXPIRE Act. H.R. 4438 American Research and Competitiveness Act of 2013. Proposals to reform domestic and international tax structures.
Proposals to reform domestic and international tax structures.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · fourth_quarter · Q4
Issues related to data privacy.
Public Law 115-97 The Tax Cuts and Jobs Act of 2017. Public Law 115-120 Making Further Continuing Appropriations for Fiscal Year 2018. Proposals to suspend or repeal the Medical Device Tax. Proposals to reform domestic and international tax structures.
Public Law 115-271 The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment Act. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs). Proposals to ensure Department of Defense coverage for emerging medical device technology. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · third_quarter · Q3
Issues related to data privacy.
Public Law 111-148 Section 6002 The Physician Payments Sunshine Act. H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Public Law 115-97 The Tax Cuts and Jobs Act of 2017. Public Law 115-120 Making Further Continuing Appropriations for Fiscal Year 2018. Proposals to suspend or repeal the Medical Device Tax. Proposals to reform domestic and international tax structures.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · second_quarter · Q2
Issues related to data privacy.
Public Law 115-97 The Tax Cuts and Jobs Act of 2017. Public Law 115-120 Making Further Continuing Appropriations for Fiscal Year 2018. Proposals to suspend or repeal the Medical Device Tax. Proposals related to the delay of the Affordable Care Act Excise Tax on High-Value Health Plans. Proposals to reform domestic and international tax structures.
Public Law 111-148 Section 6002 The Physician Payments Sunshine Act. H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Filing targets: Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · first_quarter · Q1
Issues related to data privacy.
H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Proposals regarding infant nutrition marketing. Proposals regarding US-China trade negotiations. Issues related to international price controls on drugs and devices. Issues related to the issuance of the Taiwan Regulations Governing the Management of the Review, Registration, and Permit Issuance of Food and Related Products.
Public Law 115-97 The Tax Cuts and Jobs Act of 2017. Public Law 115-120 Making Further Continuing Appropriations for Fiscal Year 2018. Proposals to suspend or repeal the Medical Device Tax. Proposals related to the delay of the Affordable Care Act Excise Tax on High-Value Health Plans. Proposals to reform domestic and international tax structures.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · third_quarter · 3A
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to suspend or repeal the Medical Device Tax. Proposals to reform domestic and international tax structures.
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R.5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals related to the prevention of Anti-Microbial Resistant Bacteria. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · first_quarter · 1A
H.R. 1892 Bipartisan Budget Act of 2018. Title IV Section 50414 - Strengthening Rules in Case of Competition for Diabetes Testing Strips. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals to introduce policies to prevent the spread of Anti-Microbial Resistant Bacteria.
H.R. 2997 21st Century AIRR Act. (FAA Reauthorization).
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to suspend or repeal the Medical Device Tax.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · fourth_quarter · Q4
Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices. Issues related to prompt payment by government hospitals.
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to suspend or repeal the Medical Device Tax. Proposals to reform domestic and international tax structures.
Issues related to medical device cybersecurity. Proposals to ensure law enforcement has tools to identify impaired drivers.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · third_quarter · Q3
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
H.R.5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals related to the prevention of Anti-Microbial Resistant Bacteria. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · second_quarter · Q2
S. 2848 Fighting Opioid Abuse in Transportation Act.
H.R.5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals related to the prevention of Anti-Microbial Resistant Bacteria. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · first_quarter · Q1
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to suspend or repeal the Medical Device Tax.
H.R. 2997 21st Century AIRR Act. (FAA Reauthorization).
H.R. 1892 Bipartisan Budget Act of 2018. Title IV Section 50414 - Strengthening Rules in Case of Competition for Diabetes Testing Strips. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals to introduce policies to prevent the spread of Anti-Microbial Resistant Bacteria.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · fourth_quarter · Q4
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017. Proposals to improve the DME competitive bidding program for diabetes products. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs). Proposals for Medicare reimbursement for diagnostic patient self-testing. Proposals to introduce policies to prevent the spread of Anti-Microbial Resistant Bacteria.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · second_quarter · 2A
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals to reform the regulation of diagnostics including Laboratory Developed Tests (LDTs). Proposals to support appropriate Medicare coverage for heart failure technology.
Proposals to reform domestic and international tax structures.
H.R.2997 - 21st Century AIRR Act (FAA Reauthorization Act).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · first_quarter · 1A
Proposals related to Affordable Care Act improvements/repeal and replace. Issues related to medical device cybersecurity.
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals regarding FDA Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs). Proposals regarding re-authorization of the Medical Device User Fee Act (MDUFA). Proposals to support appropriate Medicare coverage for heart failure technology.
Proposals to reform domestic and international tax structures.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · third_quarter · Q3
Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017. Proposals to improve the DME competitive bidding program for diabetes products. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals to support appropriate Medicare coverage for heart failure technology. Proposals to reform the FDA regulatory pathway for approval of diagnostic tests including Laboratory Developed Tests (LDTs).
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · second_quarter · 2A
H.R.2997 - 21st Century AIRR Act (FAA Reauthorization Act).
Proposals to reform domestic and international tax structures.
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals to reform the regulation of diagnostics including Laboratory Developed Tests (LDTs). Proposals to support appropriate Medicare coverage for heart failure technology.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · second_quarter · Q2
Proposals to reform domestic and international tax structures.
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals to reform the regulation of diagnostics including Laboratory Developed Tests (LDTs). Proposals to support appropriate Medicare coverage for heart failure technology.
H.R.2997 - 21st Century AIRR Act (FAA Reauthorization Act).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · first_quarter · Q1
Proposals to reform domestic and international tax structures.
Proposals related to Affordable Care Act improvements/repeal and replace. Issues related to medical device cybersecurity.
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule under PAMA. Proposals related to the use of the Unique Device Identification Code. Proposals regarding FDA Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs). Proposals regarding re-authorization of the Medical Device User Fee Act (MDUFA). Proposals to support appropriate Medicare coverage for heart failure technology.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · fourth_quarter · 4A
Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · fourth_quarter · Q4
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to the use of the Unique Device Identification Code. Proposals regarding FDA Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · third_quarter · Q3
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals regarding payments across healthcare sites of service.
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to the use of the Unique Device Identification Code. Proposals regarding FDA Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · second_quarter · Q2
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Initiatives to support patient access to therapeutic nutrition. Proposals to reduce adult malnutrition and hospital re-admissions.
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · first_quarter · Q1
Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act.
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Initiatives regarding Trade Implications of International Food Labeling Requirements. Proposals to reduce adult malnutrition and hospital re-admissions.
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · fourth_quarter · 4A
H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
H.R.22 Fixing America's Surface Transportation Act - issues related to truck weight.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · fourth_quarter · Q4
H.R.22 Fixing America's Surface Transportation Act - issues related to truck weight.
H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
H.R. 2029 Consolidated Appropriations Act 2016, Sec. 503. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015 Proposals to reform the Medicare new technology add-on payment provision for inpatient services. Proposed Hospital Inpatient Prospective Payment System Rule.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · third_quarter · Q3
S. 1946: Tax Relief Extension Act of 2015 H.R. 880, the American Research and Competitiveness Act of 2015, H.R. 1430, Permanent CFC Look-Through Act of 2015 Proposals to reform domestic and international tax structures.
S. 754 Cybersecurity Information Sharing Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · second_quarter · Q2
H.R. 1295, Medical Device Tax Elimination Act. Proposals to reform domestic and international tax structures.
Initiatives regarding implementation of Public Law 111-296 Healthy, Hunger-Free Kids Act of 2011. Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act.
S. 754 Cybersecurity Information Sharing Act.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · first_quarter · Q1
H.R. 4432 Safe and Accurate Food Labeling Act. Proposals to reduce adult malnutrition and hospital re-admissions.
H.R. 1295, Medical Device Tax Elimination Act. Proposals to reform domestic and international tax structures.
Initiatives regarding implementation of Public Law 111-296 Healthy, Hunger-Free Kids Act of 2011. Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · fourth_quarter · Q4
H.R. 4432 Safe and Accurate Food Labeling Act. Initiatives to reduce patient malnutrition and hospital readmissions
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · third_quarter · Q3
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013.
Proposals to reform domestic and international tax structures.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · second_quarter · Q2
S. 2260 EXPIRE Act. H.R. 4438 American Research and Competitiveness Act of 2013. Proposals to reform domestic and international tax structures.
Initiatives regarding implementation of Public Law 111-296 Health, Hunger-Free Kids Act of 2011. Initiatives regarding infant nutrition.
Initiatives to reduce patient malnutrition and hospital readmissions. H.R. 4432 Safe and Accurate Food Labeling Act. Initiatives to support patient access to therapeutic nutrition.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to suspend or repeal the Medical Device Tax. Proposals to reform domestic and international tax structures.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Issues related to data privacy proposals.
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to suspend or repeal the Medical Device Tax. Proposals to reform domestic and international tax structures.
H.R. 5776 MOST Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Proposals regarding infant nutrition marketing. Issues related to tariffs on products imported into the United States. Issues related to Saudi Government tender requirements. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 6 21st Century CURES Act, Sec. 2228. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity. Issues related to the implementation of the FDA Device Accountability Act of 2016.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to the use of the Unique Device Identification Code. Proposals regarding FDA Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
Proposals regarding infant nutrition marketing. Issues related to international regulatory review of drugs and devices. Issues related to international price controls on drugs and devices. Asia-Pacific Economic Cooperation Business Advisory Council.
Proposals to reform domestic and international tax structures.
S. 764 National Bioengineered Food Disclosure Standard. H.R. 1599 Safe and Accurate Food Labeling Act of 2015 Proposals to reduce adult malnutrition and hospital re-admissions.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act.
Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Proposals regarding infant nutrition marketing. Issues related to international price controls on drugs and devices.
Proposals related to legal reform. Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule. Proposed Hospital Inpatient Prospective Payment System Rule.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
H.R. 2029 Consolidated Appropriations Act 2016, Sec. 503. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015 Proposals to reform the Medicare new technology add-on payment provision for inpatient services. Proposed Hospital Inpatient Prospective Payment System Rule.
H.R. 2029 Consolidated Appropriations Act of 2016, Sec. 101. Protecting Americans from Tax Hikes Act of 2015, Sec. 121, Sec. 144, Sec. 174. Proposals to reform domestic and international tax structures.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
H.R. 2029 Consolidated Appropriations Act of 2016, Sec. 101. Protecting Americans from Tax Hikes Act of 2015, Sec. 121, Sec. 144, Sec. 174. Proposals to reform domestic and international tax structures.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)